Genetic deficiency of angiotensinogen produces an impaired urine concentrating ability in mice

Kidney International

Volumn 53, Issue 3, 1998, Pages 548-555

  Kihara, Minoru ^a   Umemura, Satoshi ^b   Sumida, Yoichi ^b   Yokoyama, Nobuyuki ^b   Yabana, Machiko ^b   Nyui, Nobuo ^b   Tamura, Kouichi ^b   Murakami, Kazuo ^b   Fukamizu, Akiyoshi ^b   Ishii, Masao ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NONE

Author keywords

Angiotensinogen and renal function; Genetic deficiency; Knockout mice; Tubulointerstial lesions; Urine concentrating ability

Indexed keywords

ANGIOTENSINOGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FLUID BALANCE; FLUID INTAKE; KIDNEY CONCENTRATING CAPACITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 15644365766     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00801.x     Document Type: Article

References (33)

1. FAUBERT PF, CHOU SY, PORUSH JG: Regulation of papillary plasma flow by angiotensin II. Kidney Int 32:472-478, 1987
2. BECKER BN, HARRIS RC: A potential mechanism for proximal tubule angiotensin II-mediated sodium flux associated with receptor-mediated endocytosis and arachidonic acid release. Kidney Int 50(Suppl 57):S66-S72, 1996
3. HALL JE: Control of sodium excretion by angiotensin II: Intrarenal mechanisms and blood pressure regulation. Am J Physiol 250:R960-R972, 1986
4. KELSER JA, BJORK EA, HODGES JC, TAYLOR JR DG: Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands. J Pharamacol Exp Ther 262:1154-1160, 1992
5. AMRANI AKE, MENARD J, GONZALES MF, MICHEL JB: Effects of blocking the angiotensin II receptor, converting enzyme, and renin activity on the renal hemodynamics of normotensive guinea pigs. J Cardinvasc Pharmacol 22:231-239, 1993
6. FRIBERG P, SUNDELIN B, BOHMAN SO, BOBIK A, NILSSON H, WICKMAN A, GUSTAFSSON H, PETERSEN J, ADAMS MA: Renin-angiotensin system in neonatal rats: Induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 45:485-492, 1994
7. SPENCE SG, ALLEN HL, CUKIERSKI MA, MANSON JM, ROBERTSON RT, EYDELLOTH RS: Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats. Teratology 51:367-382, 1995
8. TUFRO-MCREDDIE A, ROMANO LM, HARRIS JM, FERDER L, GOMHZ RA: Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 269:F110-F115, 1995
9. GURON G, ADAMS MA, SUNDELIN B, FRIBERG P: Neonatal angiotensin-converting enzyme inhibition in the rat induces persistent abnormalities in renal function and histology. Hypertension 29:91-97, 1997
10. TANIMOTO K, SUGIYAMA F, GOTO Y, ISHIDA J, TAKIMOTO E, YAGAMI K, FUKAMIZU A, MURAKAMI K: Angiotensinogen-deficient mice with hypotension. J Biol Chem 269:31334-31337, 1994
11. KIM HS, KREGE JH, KLUCKMAN KD, HAGAMAN JR, HODGIN JB, BEST CF, JENNETTE JC, COFFMAN TM, MAEDA N, SMITHIES O: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 92:2735-2739, 1995
12. NIIMURA F, LABOSKY PA, KAKUCHI J, OKUBO S, YOSHIDA H, OIKAWA T, ICHIKI T, NAFTILAN AJ, FOGO A, INAGAMI T, HOGAN BLM, ICHIKAWA I: Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96:2947-2954, 1995
13. KIHARA M, UMEMURA S, KADOTA T, YABANA M, TAMURA K, NYUUI N, OGAWA N, MURAKAMI K, FUKAMIZU A, ISHII M: The neuronal isoform of constitutive nitric oxide synthase is upregulated in the macula densa of angiotensinogen gene-knockout mice. Lab Invest 76:285-294, 1997
14. KIHARA M, UMEMURA S, YABANA M, SUMIDA Y, NYUUI N, TAMURA K, KADOTA T, KISHIDA R, MURAKAMI K, FUKAMIZU A, ISHII M: Dietary salt loading decreases the expressions of neuronal type nitric oxide synthase and renin in the juxtaglomerular apparatus of angiotensinogen gene-knockout mice. J Am Soc Nephrol (in press)
15. ESTHER CR, HOWARD TE, MARINO EM, GODDARD JM, CAPECCHI MR, BERNSTEIN KE: Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74:953-965, 1996
16. ITO M, OLIVERIO MI, MANNON PJ, BEST CF, MAEDA N, SMITHIES O, COFFMAN TM: Regulation of blood pressure by the type 1a angiotensin II receptor gene. Proc Natl Acad Sci USA 92:3521-3525, 1995
17. SUGAYA T, NISHIMAISU S, TANIMOTO K, TAKIMOTO E, YAMAGISHI T, IMAMURA K, GOTO S, IMAIZUMI K, HISADA Y, OTSUKA A, UCHIDA H, SUGIURA M, FUKUTA K, FUKAMIZU A, MURAKAMI K: Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270:18719-18722, 1995
18. HEIN L, BARSH GS, PRATT RE, DZAU VJ, KOBILKA BK: Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 377:744-747, 1995
19. QADRI F, CULMAN J, VELTMAR A, MAAS K, RASCHER W, UNGER T: Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus. J Pharmacol Exp Ther 267:567-574, 1993
20. HORKY K, SRAMKOVA J, WIDIMSKY J JR, DVORAKOVA J: Plasma concentration and urinary excretion of arginine-vasopressin in primary aldosteronism during the fluid deprivation tests. Exp Clin Endocrinol 82:347-355, 1983
21. BISSET GW, CHOWDREY HS, FAIRHALL KM, GUNN LK: Central inhibition by γ-aminobutyric acid and muscimol of the release of vasopressin and oxytocin by an osmotic stimulus in the rat. Br J Pharmacol 99:529-535, 1990
22. ZHOU XJ, VAZIRI ND, PANDIAN D, WANG ZQ, MAZOWIECKI M, LIAO SY, OVEISI F: Urinary concentrating defect in experimental hemochromatosis. J Am Soc Nephrol 7:128-134, 1996
23. KREGE JH, JOHN SW, LANGENBACH LL, HODGIN JB, HAGAMAN JR, BACHMAN ES, JENNETTE JC, O'BRIEN DA, SMITHIES O: Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146-148, 1995
24. LO M, LIU KL, LANTELME P, SASSARD J: Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest 95:1394-1397, 1995
25. CHOU SY, PORUSH JG, FAUBERT PF: Hormonal control of medullary circulation. Kidney Int 37:1-13, 1990
26. CUPPLES AWA, SAKAI T, MARSH DJ: Angiotensin II and prostaglandins in control of vasa recta blood flow. Am J Physiol 254:F417-F424, 1988
27. HANSELL P, SJOQUIST M, ULFENDAHL MR: Effect of a converting enzyme inhibitor on vasa recta blood flow in rat kidney. Am J Physiol 254:F492-F499, 1988
28. MATTSON DL, ROMAN RJ: Role of kinins and angiotensin II in the renal hemodynamic response to captopril. Am J Physiol 260:F670-F679, 1991
29. LU SH, MATTSON DL, COWLEY AW JR: Renal medullary captopril delivery lowers blood pressure in spontaneously hypertensive rats. Hypertension 23:337-345, 1994
30. FRANCHINI KG, COWLEY AW: Renal cortical and medullary blood flow responses during water restriction: Role of vasopressin. Am J Physiol 270:R1257-R1262, 1996
31. OKUBO S, NIIMURA F, NISHIMURA H, TAKEMOTO F, FOGO A, MATSUSAKA T, ICHIKAWA I: Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion. J Clin Invest 99:855-860, 1997
32. AGUILERA G: Role of angiotensin II receptor subtypes on the regulation of aldosterone secretion in the adrenal glomerulosa zone in the rat. Mol Cell Endocrinol 90:53-60, 1990
33. SHIBATA H, SUZUKI H, MARUYAMA T, MURATA K, SARUTA T: Effect of dietary chloride on aldosterone synthase induction and angiotensin II receptors in rat adrenals. Mol Cell Endocrinol 114:167-175, 1995